trastuzumab
Trastuzumab Intravenous: Uses, Side Effects, Interactions
trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients
เว็บไซต์ trastuzumab trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients trastuzumab Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short
trastuzumab trastuzumab ให้ครั้งแรก 4mgkg และให้ต่อ 2mgkg ทุกสัปดาห์จนกระทั่งมี disease progression หรือมี unacceptable toxicity ยา capecitabineในมะเร็งเต้านมระยะที่ 4 สรุปคำแนะนำ ควร Trastuzumab emtansine is a HER2-targeted, microtubule-stabilizing antibody-drug conjugate with about 3 chemotherapy molecules per antibody Trastuzumab is a biologic therapy indicated for the treatment of human epidermal growth factor receptor 2 -positive breast cancer and